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Abstract
Typhoid fever is endemic across sub-Saharan Africa. However, estimates of the burden of
typhoid are undermined by insufficient blood volumes and lack of sensitivity of blood culture.
Here, we aimed to address this limitation by exploiting pre-enrichment culture followed by
PCR, alongside routine blood culture to improve typhoid case detection. We carried out a
prospective diagnostic cohort study and enrolled children (aged 0–4 years) with non-specific
febrile disease admitted to a tertiary hospital in Blantyre, Malawi from August 2014 to July
2016. Blood was collected for culture (BC) and real-time PCR after a pre-enrichment culture
in tryptone soy broth and ox-bile. DNA was subjected to PCR for invA (Pan-Salmonella),
staG (S. Typhi), and fliC (S. Typhimurium) genes. A positive PCR was defined as invA plus
either staG or fliC (CT<29). IgM and IgG ELISA against four S. Typhi antigens was also per-
formed. In total, 643 children (median age 1.3 years) with nonspecific febrile disease were
enrolled; 31 (4.8%) were BC positive for Salmonella (n = 13 S. Typhi, n = 16 S. Typhimur-
ium, and n = 2 S. Enteritidis). Pre-enrichment culture of blood followed by PCR identified a
further 8 S. Typhi and 15 S. Typhimurium positive children. IgM and IgG titres to the S.
Typhi antigen STY1498 (haemolysin) were significantly higher in children that were PCR
positive but blood culture negative compared to febrile children with all other non-typhoid ill-
nesses. The addition of pre-enrichment culture and PCR increased the case ascertainment
of invasive Salmonella disease in children by 62–94%. These data support recent burden
estimates that highlight the insensitivity of blood cultures and support the targeting of pre-
school children for typhoid vaccine prevention in Africa. Blood culture with real-time PCR
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following pre-enrichment should be used to further refine estimates of vaccine effectiveness
in typhoid vaccine trials.
Author summary
There are increasing reports of typhoid fever epidemics in sub-Saharan Africa frequently
affecting young adults and children aged between 5 and 16 years. In Asia where typhoid is
hyperendemic, children aged 0 to 4 years also have a high burden of typhoid fever. Diag-
nosis of typhoid in young children is particularly a challenge because collection of ade-
quate blood sample for testing is not always possible and the Salmonella bacterial load is
low. Established methods of diagnosis such as blood culture and serology have low sensi-
tivity. This study has used a combination of blood culture and pre-enrichment culture fol-
lowed by PCR to improve ascertainment of the burden of both nontyphoidal Salmonella
disease and typhoid fever in Malawian children, aged 0 to 4 years. We found that diagnosis
with blood culture and pre-enrichment culture followed by PCR together added 94%
more of nontyphoidal Salmonella and 62% more of Salmonella Typhi than blood culture
alone. Where blood culture was negative but Salmonella-specific PCR was positive we
have validated our results using Haemolysin (STY1498)-based serology. There are ongo-
ing typhoid vaccine efficacy trials in Africa and Asia. The findings from this study will
inform future estimates of vaccine effectiveness.
Introduction
Both Salmonella Typhi and nontyphoidal Salmonellae remain prominent contributors to the
large burden of bloodstream infection (BSI) in sub-Saharan Africa (sSA) [1–4]. Until recently
nontyphoidal serovars Salmonella Typhimurium and Salmonella Enteritidis were the most
prevalent in sSA, mainly affecting young children and HIV-infected adults [5–7]. Outbreaks of
typhoid fever are now being reported across sSA [1, 8–11], largely caused by a multidrug resis-
tant S. Typhi genotype 4.3.1 [12–14]. In Malawi where surveillance for bloodstream infections
has been conducted for over 20 years, S. Typhi has become one of the commonest blood cul-
ture isolates amongst hospitalized febrile adults and children [1, 15]. In this context, ineffec-
tive, commonly available antimicrobials and inadequate diagnostic tools with poor sensitivity
and results turn-around time, hamper the identification, management and control of both
iNTS and typhoid fever.
Blood culture identifies 40 to 80% of cases of invasive Salmonella disease [16]. Limitations
of culture arise due to low numbers of bacteria in blood, requiring large volume samples that
are not feasible from young children [17]. Prior antimicrobial use may further compromise
the diagnostic yield. Currently available, commercial serological tests detecting antibody
against S. Typhi antigens have limited sensitivity and poor specificity [18–20]. A number of
PCR methods for diagnosis of Salmonella have been developed. The inclusion of a culture step
prior to nucleic acid amplification has been suggested to increase sensitivity [21, 22], but this
has not been evaluated in the field.
Studies from countries in Asia with endemic typhoid suggest a considerable disease burden
in young children, including children aged under 4 years [3, 23–25]. If this is also the case in
sSA, this could influence the age at which vaccination might be implemented within the
National vaccination expanded programme on immunisation [26]. In this study, we adopted
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real-time PCR with a pre-enrichment culture step alongside standard blood culture to improve
case ascertainment of invasive Salmonella disease in children aged under 4 years in Malawi.
Methods
Ethics statement
The College of Medicine Research Ethics Committee approved the study, approval number
P.08/13/1445. Written informed consent was sought from the parents or guardians before
enrolment of participants into the study.
Participant enrolment
Recruitment of participants into the study was nested within the pre-existing sentinel surveil-
lance for bacterial infections at Queen Elizabeth Central Hospital (QECH) and the Malawi-
Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. Children with
non-specific febrile illness (temperature�38˚C or a history of fever) aged between 0 and 4
years old presenting to QECH were recruited. QECH is the largest government hospital in
Malawi, providing free healthcare to the district of Blantyre with a population of approxi-
mately 1.3 million and referrals from the Southern region [27]. Recruitment was from August
2014 to July 2016 covering three dry seasons and two rainy seasons. 5 mL blood was drawn
from each child; 2 mL for culture, 2 mL for real-time PCR and 1 mL for serology. At six weeks
in convalescence further 1 mL of blood was drawn and plasma was extracted for serology.
Unless invasive bacterial infection was strongly suspected, children with a positive RDT or
malaria blood film were not enrolled into the study.
Blood culture processing
Blood cultures were processed using the BacT/Alert automated system (Biomerieux, France),
at the Malawi-Liverpool-Wellcome Trust Clinical Research Laboratories [1]. Bacteria were iso-
lated and identified using previously described standard microbiological procedures [1]. A
minimum of four days, including sub-culturing, biochemical testing and latex agglutination
testing, was necessary to generate a definitive report of the diagnosis.
Pre-enrichment
A modified pre-enrichment procedure for Salmonella was adopted [28]. A maximum of 2 mL
of blood was added to 8 mL of tryptone soy broth mixed with 3% Ox-gall powder (TSB/Ox-
gall) and incubated overnight at 37˚C. Blood samples with<2 mL were added to 8 mL TSB/
Ox-gall medium, topped up to 10 mL with sterile distilled water.
DNA extraction and real-time PCR
Pre-enriched blood samples were centrifugated in a macrocentrifuge at 3000 x g and the super-
natant pipetted out leaving approximately 200 μl to resuspend the pellets. DNA from blood,
including bacterial genomic DNA, was extracted following the UltraClean BloodSpin Kit (MO
BIO Laboratories CA USA) extraction protocol. DNA was eluted in a final volume of 100 μl
and stored at -20˚C. A 40-cycle real-time PCR was performed using a mastermix of Platinum
Quantitative UDG reagents on an ABI 7500. Three primer pairs (Table 1) designed using
Primer Quest, were added in monoplex reactions (S1 Table) to detect the presence of either S.
Typhi or S. Typhimurium. A pan-Salmonella primer pair targeting invA was designed using
sequences from S. Typhimurium ST313 D23580 (Accession FN424405) and S. Typhi CT18
(Accession AL513382). A primer pair specifically identifying S. Typhimurium was designed
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against the flagellin gene fliC and S. Typhi was detected using a primer pair targeting the fim-
brial gene staG.
Establishing a cycle threshold cut-off
A positive PCR result was assigned to a sample only if the pan-Salmonella (invA) amplification
was simultaneously positive with either one of the serovar-specific amplifications (fliC or staG)
within a specified cycle threshold (CT) cut-off. The CT-value cut-off was determined using a
combination of three approaches. Firstly, the primer pairs were tested against DNA extracted
from serially diluted cultures of S. Typhi, S. Typhimurium, Staphylococcus aureus, E. coli, Kleb-
siella pneumoniae, Micrococcus spp., and Bacillus spp (S2 Table). Five replicates were prepared
for each organism. A cut-off was set to exclude all CT-values observed for non-specific target
amplifications. Secondly, the limit of target detection was established for the three primer pairs
by running the real-time PCR assay on five replicates of serially diluted cultures of S. Typhi
and S. Typhimurium. Thirdly, a receiver operating characteristic (ROC) curve was constructed
to assess the cut-off value that maximises sensitivity and specificity of the PCR amplification,
considering the blood culture result as a true positive.
S. Typhi serology
Serology for S. Typhi (Table 2), with previously identified serodiagnostic antigens [29, 30] and
S. Typhi Vi polysaccharide antigen [31], was conducted to validate the PCR amplification data
in blood culture negative samples. Sera from febrile children acutely ill and plasma at six weeks
in convalescence were analysed. Archived serum samples from healthy Malawian children
aged 0 to 4 years (median age 10 months) were included in the analysis as controls [32]. IgM
and IgG titres in acute and convalescent plasma samples and in healthy control sera were mea-
sured using a previously described ELISA with 3 purified protein antigens STY1498 (Haemoly-
sin), STY1479 (a possible ATP binding protein), STY1886 (cytolethal distending toxin subunit
B homolog) and S. Typhi Vi polysaccharide antigen.
Table 1. Primer and probe sequences.
Primer Sequence Source
invA Forward AGCGTACTGGAAAGGGAAAG This study
Probe FAM-TTACGGTTCCTTTGACGGTGCGAT-BHQ1
Reverse CACCGAAATACCGCCAATAAAG
staG Forward CCGACCAAGTTCCAGATCAA This study
Probe VIC-TGGCCAGTAATAATGTCGGGACGA-BHQ1
Reverse GTTGGTTAGTAGCGAGGTGTT
fliC Forward TGCTGATTTGACAGAGGCTAAA This study
Probe FAM-TGTTACCGGCACAGCATCTGTTGT-BHQ1
Reverse TCGCCTACCTTAACTGCTAAAC
https://doi.org/10.1371/journal.pntd.0007539.t001
Table 2. Salmonella Typhi antigens for ELISA confirmation of blood culture negative/ PCR positive samples.
Antigen ID Annotation
STY1498 Haemolysin
STY1479 Possible ATP binding protein
STY1886 Cytolethal distending toxin subunit B homolog
VI Vi polysaccharide
https://doi.org/10.1371/journal.pntd.0007539.t002
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Statistical analysis
Fisher’s exact test and Chi-squared test were used to determine whether clinical characteristics
(fever, vomiting and diarrhoea), hospital admission and reported prior use of antibiotics were
related to detection of Salmonella by both culture and PCR. Statistical significance was defined
as P< 0.05, although exact p-values were reported. Pearson’s correlation coefficient was used to
analyse the association between blood sample volume and cycle threshold value on PCR. Anti-
body (IgG and IgM) titre differences between S. Typhi positive and negative groups were log-
transformed and tested using two-tailed two-sample t-tests and we also looked for differential
clustering between these 2 groups using multidimensional scaling and principal component
analysis. Analyses were performed using IBM Corp. Released 2011. IBM SPSS Statistics for
Windows, Version 20.0. Armonk, NY: IBM Corp, GraphPad prism version 7.0 and R v3.5.1.
Results
Study population
A total of 661 children aged less than 4 years (median age 15.9 months; range 1–48 months;
357 males), with non-specific febrile disease were recruited at QECH over the study period.
Eighteen children were excluded from the analysis; 5 had no blood culture results, 4 had no
PCR sample, and 9 had inconclusive PCR results on re-testing (Fig 1).
The baseline characteristics of the 643 children in these analyses are presented in Table 3.
Real-time PCR and CT-value cut-off
Real-time PCR amplifications were generated in 323 pre-enriched blood samples for the pan-Sal-
monella primers, in 234 for the S. Typhimurium specific primers, and for 168 of the S. Typhi spe-
cific primers, and the remaining 320 samples were negative. The CT values ranged from 8.643 to
39.857 for the pan-Salmonella primers (median = 33.713, interquartile range (IQR) 30.476–
35.662), from 10.855 to 39.9997 for the S. Typhimurium specific primers (median = 34.765, IQR
32.237–36.066), and 9.849 to 38.868 for the S. Typhi specific primers (median = 33.978, IQR
31.872–36.708). A plot of the CT-values generated bimodal distributions for each of the three
amplifications (Fig 2). A cut-off was set at CT = 29 because non-specific PCR amplifications gen-
erated in validation experiments clustered above a CT value of 29 (Fig 3). An ROC curve showed
that a CT value of 29 cut-off maximised sensitivity and specificity of the respective PCR primer
pairs to identify S. Typhi (invA: Sensitivity = 84.6%, Specificity = 92.9%; staG: Sensitivity = 76.9%,
Specificity = 98.7%) and S. Typhimurium (invA: Sensitivity = 68.8%, Specificity = 92.8%; fliC:
Sensitivity = 68.8%, Specificity = 97.0%) (S1 Fig and S3 Table)
Blood culture and PCR diagnosis
A positive blood culture was recorded in 15.4% (99/643) of the recruited children. Nine patho-
gens were isolated including the Salmonella enterica serovars Typhi, Typhimurium and Enteri-
tidis (Table 4). S. Typhimurium was the major NTS serovar with 88.9% (16/18) of NTS
isolates. Thirteen of the 643 children had an S. Typhi infection; all were older than one year of
age and 84.6% (11/13) of them were between 2 and 4 years old. Contaminated blood culture
growth was present in 8.9% (57/643) of the study participants. Real-time PCR with pre-enrich-
ment added an additional 8 S. Typhi infections and 15 additional S. Typhimurium infections.
Three S. Typhi and 5 S. Typhimurium cases had a positive blood culture but were negative by
real-time PCR (Table 5). In the study population, the combination of blood culture and real-
time PCR with pre-enrichment detected S. Typhimurium and S. Typhi positivity frequencies
of 4.8% (31/643) and 3.3% (21/643) respectively.
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Clinical characteristics, antimicrobial use and Salmonella detection
Non-specific clinical presentations including fever, vomiting and diarrhoea were common and
there was no association between clinical signs or symptoms and detection of either S. Typhi or
S. Typhimurium infection (P range 0.27 to 0.79). However, hospital admission was more fre-
quent in children with S. Typhimurium infection (23/31; 74.1%) than those with typhoid fever
(8/21; 38.0%) (P = 0.02). Reported prior-antibiotic use (288/642; 44.9%) was not significantly
associated with lack of growth of either S. Typhi (P = 0.22) or nontyphoid Salmonella (P = 0.93).
Real-time PCR and sample volume
Blood sample volumes were recorded in 619 of the 643 recruited children. The targeted vol-
ume of blood (2 mL) for real-time PCR was achieved in 100 /619 (16.2%) children. The mini-
mum volume of blood sample collected for PCR after venesection for blood culture was 100μl
(median = 1,200μl, IQR 1,000μl– 1,725μl). There was no correlation between the CT value and
Fig 1. Flowchart of participant recruitment. Numbers of children screened, recruited and processed on PCR, blood
culture and serology are provided.
https://doi.org/10.1371/journal.pntd.0007539.g001
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the volume of the pre-enriched blood sample for the pan-primer (P = 0.35, r = .05), S. Typhi
specific primer (P = 0.59, r = .04), and S. Typhimurium specific primer (P = 0.13, r = .10) (S2
Fig).
Typhoid IgG and IgM confirmation of PCR diagnostics
Serum was sampled from 445 children at the time of illness; 142 provided additional plasma
sample six weeks after the admission date. All the 445 febrile children (regardless of presence
or absence of S. Typhi infection) had significantly elevated IgM and IgG titres against all four
antigens, compared to healthy controls (n = 61) (P range<0.0001 to 0.0394) (S3 Fig). IgM and
IgG responses in acute typhoid infection, confirmed by both blood culture and PCR (or blood
Table 3. Characteristics of 643 children� 4 years.
Characteristic Children� 4yrs
n (%)
Number 643
Sex, male 351 (54.6)
Age, months, median [IQR] 15.8 [8.9–28]
1–8.9 165 (25.5)
9–16.9 172 (26.7)
17–24.9 114 (17.7)
25–48 192 (29.7)
Vomiting 261/641 (40.7)
Diarrhoea 227/641 (35.4)
Malaria positive by RDT or Blood Film Microscopy 20/640 (3.1)
Recruitment by season, wet 360 (56.0)
Hospital admission 252/639 (39.4)
Prior reported antibiotic use 288/642 (44.9)
https://doi.org/10.1371/journal.pntd.0007539.t003
Fig 2. Bimodal distribution of CT-values for primers invA, fliC and staG. Graph shows the distribution of CT-
values for the salmonella pan primer and S.Typhi and S.Typhiurium specific primers with a clear distinction between
PCR positives and negatives.
https://doi.org/10.1371/journal.pntd.0007539.g002
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Fig 3. CT cut-off set to demarcate non-specific amplification signals for primers invA (a), fliC (b) and staG (c). Graph shows CT-values from serial
dilutions of contaminants; Micrococci (mc), Bacillus (bac), and pathogens; S. Typhi (sty), S. Typhimurium (stm), S. aureus (sta), Klebsiella (klb), and E. coli
(eco).
https://doi.org/10.1371/journal.pntd.0007539.g003
Table 4. Blood culture growth observed in the study population.
Blood culture growth n (%)
Pathogens:
E. coli 3 (0.5)
Enterobacter spp 1 (0.2)
Pantoea spp 1 (0.2)
Pseudomonas aeruginosa 1 (0.2)
Salmonella Enteritidis 2 (0.3)
Salmonella Typhi 13 (2.0)
Salmonella Typhimurium 16 (2.5)
Staphylococcus aureus 3 (0.5)
Streptococcus pyogenes 2 (0.3)
Contaminants:
α-haemolytic Streptococci 4 (0.6)
Bacillus spp. 10 (1.5)
Coagulase negative Staphylococcus 22 (3.4)
Diphtheroids 4 (0.6)
Micrococcus spp 17 (2.6)
No growth 544 (84.6)
Total 643 (100)
https://doi.org/10.1371/journal.pntd.0007539.t004
Table 5. PCR performance in relation to Blood culture.
Blood culture Sensitivity (%) Specificity (%) PPV (%) NPV (%)
+ -
S.Typhi PCR + 10 8 76.9 98.7 55.6 99.5
- 3 622
S. Typhimurium PCR + 11 15 68.8 97.6 42.3 99.2
- 5 612
https://doi.org/10.1371/journal.pntd.0007539.t005
Ascertaining the burden of invasive Salmonella disease
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007539 July 17, 2019 8 / 16
Ascertaining the burden of invasive Salmonella disease
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007539 July 17, 2019 9 / 16
culture alone) (n = 10) against STY1498 were significantly elevated in comparison to responses
in febrile children with all other non-typhoid illnesses (n = 428) (IgM, P = 0.0172; IgG,
P = 0.0001) (Figs 4 and 5). The concentration of IgG against STY1498 in convalescent plasma
from children who previously had a negative blood culture but were PCR amplification posi-
tive for S. Typhi were significantly higher than in children with non-typhoid illnesses (P<
0.0001) (Fig 4). There was no significant difference in IgM or IgG titres (P> = 0.05) against
STY1479, STY1886 or Vi between children with typhoid infection and those with other ill-
nesses (Figs 4 and 5). Further, neither multidimensional scaling nor principal component
analysis, when run on both IgM and IgG titres for all four antigens, was able to clearly separate
Salmonella positive from negative cases on blood culture and / or PCR (S4 Fig).
Discussion
The precise epidemiology of invasive Salmonella infections remains elusive in many resource-
limited settings [33, 34]. We have utilised a combination of blood culture and real-time PCR
with pre-enrichment to improve ascertainment of S. Typhi and S. Typhimurium bacteraemia
in young children by 62% and 94% respectively.
In sub-Saharan Africa, including Malawi, invasive nontyphoidal Salmonellae (iNTS) has
been widely reported in children less than five years old [5, 6], leading to preventive strategies
being targeted towards this age group [35]. In the context of multiple reports of declining inci-
dence of iNTS in the region [1, 36], our findings suggest that the residual burden of this high
mortality bloodstream infection may be greater than supposed. In contrast to iNTS, the con-
ventional understanding has been that typhoid fever is a disease of older children and adults
[25, 37, 38]. Our data suggests a considerable hidden burden in children 0–4 years who present
with non-specific clinical features. We speculate that an even greater number of cases are pre-
senting to community health centres and receiving only partially effective antibiotics.
The performance of both real-time PCR with culture pre-enrichment and blood culture is
likely to have been limited by small volumes of blood available from young children and prior
antibiotic use [39]. Nonetheless, real-time PCR with pre-enrichment did identify additional
cases to blood culture with few false negatives. Reported prior use of antibiotics, which is
expected to impact negatively both real-time PCR with culture pre-enrichment and blood cul-
ture, was found not to have affected detection of invasive salmonella infection. However, the
unreliable nature of reported use of antibiotics [40, 41] may mean that our findings may still
be an underestimate of invasive Salmonellosis in young children.
To validate case ascertainment by pre-enrichment PCR in the context of a negative blood
culture, we have used antibody-based diagnostics [42, 43], which are not dependent on bacte-
rial concentration in the blood but can vary between populations [44]. In this study IgM and
IgG antibody responses to S. Typhi antigens Vi and CdtB (STY1886) in Malawian children
were not serodiagnostic as previously reported in Vietnamese [30] and Bangladeshi [31] popu-
lations. Only IgG and IgM responses to STY1498 (haemolysin gene, hlyE) separated S. Typhi
cases confirmed by blood culture and PCR with culture pre-enrichment, from those with
Fig 4. Distribution of IgG antibody titres during acute infection (A, C, E, G) and in convalescence (B, D, F, H). IgG
antibody titres were measured against four antigens (STY1498 in A & B, STY1479 in C & D, STY1886 in E & F, & Vi in G & H)
across distinct groups of children. The groups are bc+PCR+ (cases that had S. Typhi infection confirmed by both blood culture
and PCR (or blood culture alone), in acute infection [age 14 to 45, median 37 months], and in convalescence [age 14 to 45,
median 33 months]), PCR+ (S. Typhi infection confirmed by PCR only, in cute infection [age 8 to 46, median 22 months] and
in convalescence [age 22 to 46, median 40 months]), Negative (febrile but negative for typhoid on blood culture and PCR, in
acute infection [age 1 to 48, median 13.5 months] and in convalescence [age 1 to 45, median 16 months]), and Control (afebrile
healthy controls [age 0 to 52.5, median 10.2 months]).
https://doi.org/10.1371/journal.pntd.0007539.g004
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illness due to other infections. The serodiagnostic capacity of STY1498 in Malawian children
was evident in sera from active infection, as described for Vietnamese population [30], and
also in convalescent plasma screening. STY1498 serology also validated the blood culture nega-
tive/ PCR negative results.
In conclusion, the combination of real-time PCR with culture pre-enrichment with blood
culture improved case ascertainment among children aged between 0 and 4 years. These data
highlight the hidden burden of invasive Salmonellosis in young children and support the tar-
geting of pre-school children for typhoid vaccine prevention. The recent roll-out of a typhoid
conjugate vaccine trial in Malawi and subsequent implementation will likely avert a greater
burden of disease than previously reported. However, impact assessment of the vaccine may
be affected by poor sensitivity of blood culture which is the primary endpoint for the vaccine
trial. Future vaccine trial designs should consider using a combination of blood culture and
real-time PCR with culture pre-enrichment as part of the evaluation of the full impact of the
intervention.
Supporting information
S1 STROBE. A check list of items relevant to this report of a prospective diagnostic cohort
study.
(DOC)
S1 Fig. Receiver operating curve characteristic for the pan-primer and S. Typhi specific
primer in (a) and for the pan-primer and S. Typhimurium specific primer in (b). Gener-
ated from CT-values plotted against the blood culture ‘reference standard results’.
(TIF)
S2 Fig. Distribution of CT-values according to volume of blood sample pre-enriched for
PCR. Graphs show distribution according to (a) pan-primer invA, (b) S. Typhi specific primer
staG, (c) S. Typhimurium specific primer fliC. Red triangle = PCR positive for S. Typhi, Blue
rectangle = PCR positive for S. Typhimurium, and Black circle = PCR negative.
(TIF)
S3 Fig. IgM and IgG antibody responses to four antigens (STY1886, STY1479, STY1498
and VI) in febrile children and healthy controls. The graph shows significantly higher IgM
(blue) and IgG (red) levels in febrile children (n = 445) than IgM (clear) and IgG (purple) lev-
els in healthy community controls (n = 61).
(TIF)
S4 Fig. Multidimensional scaling and Principal component analysis of IgM and IgG
responses to all four antigens (STY1886, STY1479, STY1498 and VI). (1) is IgM and IgG
responses where blood culture and PCR were positive for Salmonella. (3) is IgG and IgM
responses where blood culture was positive for Salmonella and PCR was negative. (4) is IgG
and IgM responses where PCR was positive for Salmonella and blood culture was negative. (7)
Fig 5. Distribution of IgM antibody titres during acute infection (A, C, E, G) and in convalescence (B, D, F, H). IgM
antibodies were measured against four antigens (STY1498 in A & B, STY1479 in C & D, STY1886 in E & F & Vi in G &H)
across distinct groups of children. The groups are bc+PCR+ (cases that had S. Typhi infection confirmed by both blood culture
and PCR (or blood culture alone), in acute infection [age 14 to 45, median 37 months], and in convalescence [age 14 to 45,
median 33 months]), PCR+ (S. Typhi infection confirmed by PCR only, in cute infection [age 8 to 46, median 22 months] and
in convalescence [age 22 to 46, median 40 months]), Negative (febrile but negative for typhoid on blood culture and PCR, in
acute infection [age 1 to 48, median 13.5 months] and in convalescence [age 1 to 45, median 16 months]), and Control (afebrile
healthy controls [age 0 to 52.5, median 10.2 months]).
https://doi.org/10.1371/journal.pntd.0007539.g005
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is IgG and IgM responses where both blood culture and PCR were negative for Salmonella.
Ctrl are healthy controls.
(TIF)
S1 Table. Concentrations of primers and probes for the PCR reaction.
(PDF)
S2 Table. Bacterial colony forming units per mL. Concentrations of bacteria serially diluted
and DNA extracted to assess PCR non-specific amplification.
(PDF)
S3 Table. Area under the curve for the receiver operating curve. The pan-primer and S.
Typhi primer in (a) and the pan-primer and S. Typhimurium primer in (b).
(PDF)
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